Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Leucine-rich repeat kinase 2 (LRRK2) is implicated in familial Parkinson's disease (PD).
• The physiological function of LRRK2 beyond its role in PD is largely unknown.
• LRRK2 exhibits higher expression in peripheral organs like kidney, spleen, and lung compared to the brain in mice.

Purpose of the Study:

• To investigate the physiological function of LRRK2.
• To analyze age-related changes in LRRK2 expression in various mouse organs.
• To determine the specific cell types expressing LRRK2 in the spleen.

Main Methods:

• Quantitative analysis of LRRK2 mRNA and protein expression across different ages and tissues (kidney, lung, spleen, brain).
• Isolation and purification of spleen cells for LRRK2 expression analysis.
• Assessment of B lymphocyte populations using the CD19 marker and its correlation with LRRK2 expression.

Main Results:

• LRRK2 expression remained constant in kidney, lung, and brain regions throughout adult life.
• A significant age-dependent decrease in both LRRK2 mRNA and protein was observed in the spleen.
• LRRK2 expression was predominantly found in B lymphocytes within the spleen, with no expression in T lymphocytes.
• CD19 mRNA expression, a marker for B lymphocytes, also showed an age-dependent decline in the spleen.

Conclusions:

• LRRK2 may have a novel physiological function within the immune system, specifically in B lymphocytes.
• The age-dependent decrease in LRRK2 expression in spleen B lymphocytes suggests a role in immune system aging or function.
• Further research into LRRK2's role in B lymphocytes could provide insights into immune-related disorders and aging processes.